As of Apr 29
| -0.17 / -0.79%|
The 8 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 46.50, with a high estimate of 56.00 and a low estimate of 30.00. The median estimate represents a +116.88% increase from the last price of 21.44.
The current consensus among 8 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.